Cipla gets FDA green light for generic NexiumNexium and its generic versions had a market of approximately $70 million for the 12 months ended November 2019, according to IQVIA. Amneal donates hydroxychloroquine sulfate to Texas Amneal is donating one million hydroxychloroquine sulfate tablets to Texas, following a donation of two million tablets to New York. Mylan voluntarily waives marketing exclusivity for generic Kaletra Mylan will enable generic applicants to be eligible for FDA approval if Kaletra is found effective in treating COVID-19. Avion introduces Gloperba Avion's Gloperba in a liquid oral solution is now available to treat gout. Camber launches generic Lyrica Camber's generic Lyrica is available in dosage strengths of 25, 50, 75, 100, 150, 200, 225, and 300 mg. FDA institutes shortened approval pathway for biosimilars The FDA has enacted a shortened regulatory pathway for certain biologics, which will allow for faster approvals and increased competition. Lupin launches generic Diprolene Betamethasone dipropionate ointment had a market value of approximately $21 million, according to IQVIA January 2020 data. Generic drug patent cases disrupted by COVID-19 The 30-month stay deadline surrounding generic drug patent disputes is being hampered by courts limiting access and attorneys cutting back on travel. Dr. Reddy's debuts generic Daraprim Daraprim (pyrimethamine) had a market value of approximately $10 million for the most recent 12 months ended January 2020, according to IQVIA. Pharma companies ramp up production of hydroxychloroquine to support COVID-19 response Several pharmaceutical companies are making a commitment to respond to COVID-19 by donating or accelerating the production of hydroxychloroquine. First Previous 145 146 147 148 149 Next Last